Bone Marrow Transplant Program Fills Gap in Adult Care
In a significant programmatic step forward, the UC Cancer Institute has launched an adult bone marrow transplant service as a new component of its hematologic malignancies (blood cancers) program.
Led by interim director Frank Smith, MD, the program is a collaborative effort of UC Health and the UC College of Medicine. Inpatient care will take place at University Hospital and outpatient care at the Barrett Center.
"We are building the foundation of an academically focused, world-class transplantation program, says George Atweh, MD, director of the UC Cancer Institute and head of the division of hematology oncology at the College of Medicine. "We have a great team assembled, excellent clinical facilities and a commitment to conducting the clinical research that will result in better treatments for blood cancers.
UC is currently recruiting a permanent director for the program and two additional medical oncologists who specialize in treating blood diseases.
The UC bone marrow transplant service and hematologic malignancies program will bring innovative treatment options to the Greater Cincinnati area through clinical trials.
"Bone marrow transplant is required for the treatment of many blood diseases. We now have the team and infrastructure to offer this critically important service to cancer patients in the Tristate area. It is also our mission to find ways to use bone marrow transplant most effectively, says Smith, Marjory J. Johnson Endowed Chair and Professor of Pediatrics and Medicine at the College of Medicine.
To accommodate the inpatient service, University Hospital has created a dedicated unit within the critical care pavilion designed to reduce infection risk. The unit includes individualized HEPA-filtered, positive pressure rooms that maintain an air flow out of the room, reducing the likelihood of contaminants reaching the patient. Additional space with the same infection-control measures is available in the intensive care unit for patients who need extra attention post-procedure.
About Bone Marrow Transplant
Treatment with bone marrow transplant involves collecting stem cellswhich are produced in the bone marroweither from the cancer patient or a donor. These stem cells are then infused back into the patient after high dose chemotherapy cancer treatment is complete to help restore bone marrows ability to produce red and white blood cells that fight off infection.
Stem cells are collected, stored and prepared for transplantation by experts at the Hoxworth Blood Center. Most often, blood is taken from the patient and passed through a machine that separates stem cells from all the other blood components. These stem cells are frozen for re-infusion once the patients treatment is complete.
UC Health Bone Marrow Transplant Team
Frank Smith, MD, Interim Director
Tahir Latif, MD, Medical Oncologist
Neetu Radhakrishnan, MD, Medical Oncologist
Catherine Tierney, Nurse and BMT Program Coordinator
Katherine Hanger, PharmD, Clinical Pharmacist
Tammy Ward, Dietitian
Jennifer Wuest, Social Worker
The UC Health bone marrow transplant team is part of the Cincinnati Cancer Center, a partnership of the UC College of Medicine, Cincinnati Childrens Hospital Medical Center and UC Health. By leveraging the individual cancer strengths of each institution, the CCC will be able to advance care faster, especially for those with complex disease. To learn more, call Laureen McCorkle at 513-558-9879.
Related Stories
Information Security Roadshow spreads awareness
May 3, 2024
The University of Cincinnati's Office of Information Security launched a series of 18 in-person sessions from January to April 2024, drawing nearly 350 attendees from the staff of various UC colleges and units. The Information Security Roadshow series aimed to equip the audience with knowledge on prevailing cyber threats, prevention strategies, how to report incidents and resources to stay informed and secure.
Local 12: Diabetes study focuses on how long blood sugar control...
May 3, 2024
The University of Cincinnati's Robert Cohen spoke with Local 12 about the GRADE study that shows how a new medication needs to be developed to help treat people with type two diabetes.
Local media cover $13.5 million gift benefiting ALS research and...
May 2, 2024
A historic $13.5 million gift from the estate of Hugh H. Hoffman will revolutionize amyotrophic lateral sclerosis (ALS) at the ALS Multidisciplinary Clinic at the University of Cincinnati Gardner Neuroscience Institute.